GlassScriptPhysician profile
Shirley Davidoff
NPI 1457346447
$2,038.56
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $746 · 2022: $313 · 2023: $774 · 2024: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $980.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $979.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $392.39 | 2021-2023 | Xarelto |
| Heartflow, INC. | $329.60 | 2021-2023 | Ffrct |
| Pfizer INC. | $314.03 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $213.70 | 2022-2024 | Verquvo |
| Novartis Pharmaceuticals Corporation | $203.75 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $125.43 | 2021-2024 | Eliquis, Camzyos |
| Abbott Laboratories | $96.57 | 2021 | |
| Impulse Dynamics (USA) INC. | $87.45 | 2023 | Optimizer |
| Novo Nordisk INC | $55.84 | 2022-2023 | Ozempic, Rybelsus |
| Itamar Medical INC | $48.22 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $43.49 | 2021-2023 | Brilinta, Andexxa |
| Actelion Pharmaceuticals US, INC. | $27.60 | 2024 | Uptravi, Opsumit |
| Resmed Corp | $22.68 | 2023 | |
| Kiniksa Pharmaceuticals, LTD. | $22.04 | 2023 | Arcalyst |
| Esperion Therapeutics, INC. | $21.09 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $19.22 | 2024 | Arcalyst |
| Boston Scientific Corporation | $15.46 | 2023 | Wavewriter Alpha Prime 16 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shirley Davidoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.